Benjamin L Palleiko is CHIEF EXECUTIVE OFFICER of KalVista Pharmaceuticals, Inc.. Currently has a direct ownership of 395,189 shares of KALV, which is worth approximately $4.24 Million. The most recent transaction as insider was on Dec 30, 2020, when has been sold 358 shares (Common Stock) at a price of $6.74 per share, resulting in proceeds of $2,413. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 395K
1.83% 3M change
57.57% 12M change
Total Value Held $4.24 Million

Benjamin L Palleiko Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 30 2020
BUY
Exercise of conversion of derivative security
$2,413 $6.74 p/Share
358 Added 1.08%
32,858 Common Stock
BLP

Benjamin L Palleiko

CHIEF EXECUTIVE OFFICER
Cambridge, MA

Track Institutional and Insider Activities on KALV

Follow KalVista Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KALV shares.

Notify only if

Insider Trading

Get notified when an Kal Vista Pharmaceuticals, Inc. insider buys or sells KALV shares.

Notify only if

News

Receive news related to KalVista Pharmaceuticals, Inc.

Track Activities on KALV